Annovis Bio plans three presentations at CTAD conference

ANVS•2026-10-22

Annovis Bio plans three presentations at the Clinical Trials on Alzheimer's Disease conference in Boston from Nov. 16-19, 2026.

1. Conference presentations

An oral presentation on buntanetap's mechanism of action is scheduled for Nov. 19 at 3:52 p.m. ET. Posters on buntanetap's pivotal early Alzheimer's study and AI-based drug evaluation will be displayed from Nov. 16 at 2 p.m. through Nov. 17 at 5:30 p.m. ET.

Annovis Bio plans three presentations at CTAD conference

1. Conference presentations

Related News

Large national dairy achieves 17% sales lift with Repositrak Touchless Retail

Stocks fall as Meta dents AI optimism; French bonds under fire

MBX Biosciences files initial beneficial ownership statement for director Peter Radovich

UBS announces third-quarter results presentation

Aspen Aerogels publishes update to financial calendar